Jessica Kaffenberger

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

Andrew Blauvelt, Kim Papp, Alice B. Gottlieb et al. · British Journal of Dermatology · 2019 · 172 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +15

A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

Alice B. Gottlieb, Nicola E. Natsis, Francisco A. Kerdel et al. · Journal of Investigative Dermatology · 2020 · 88 citations

Medicine, Dermatology, Immunology +3

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · JAMA Dermatology · 2022 · 43 citations · Full text

Medicine, Dermatology, Pediatrics +13

Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients

Paul Macklis, Kelly Tyler, Jessica Kaffenberger et al. · Archives of Dermatological Research · 2021 · 37 citations

Public Health, Health Promotion, Pharmacotherapy +6

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States

Megan H. Noe, Marilyn T. Wan, Arash Mostaghimi et al. · JAMA Dermatology · 2021 · 29 citations · Full text

Medicine, Dermatology, Pathology +9